GHK-Cu Injection Safety Information

GHK-Cu (copper tripeptide-1) is a naturally occurring peptide bound to a copper ion. It has been studied for its role in collagen production, skin remodeling, and wound repair, and has been used for years in topical skincare.

At Belle, GHK-Cu is offered in compounded injectable form, prescribed when deemed clinically appropriate by a licensed healthcare provider. Please review the following important safety information before beginning treatment.

This Page Covers the Injection, Not the Cream

Belle offers GHK-Cu in two different products: a topical Copper Peptide Cream and a compounded injectable. They are not interchangeable, and their safety considerations are different. A cream sits on the surface of the skin; an injection delivers copper systemically, bypassing the skin barrier. Because of that, the precautions below place far more weight on copper metabolism, liver and kidney function, and zinc balance than the topical safety information does.

If you are using the cream rather than the injection, refer to the Copper Peptide Cream safety information instead.

What Is Injectable GHK-Cu?

Compounded injectable GHK-Cu is not approved by the FDA for any indication. It has not been evaluated by the FDA for skin, hair, wound healing, anti-aging, or any other purpose. It is not intended to diagnose, treat, cure, or prevent any disease.

The topical use of GHK-Cu is comparatively well characterized. Injectable use is not. Well-controlled human studies of injected GHK-Cu are limited, and long-term safety by this route has not been established. Your provider can help you weigh what is known against what is not.

Always consult your healthcare provider before beginning any injectable regimen, especially if you have pre-existing health conditions.

Who Should Not Use Injectable GHK-Cu

Injectable GHK-Cu should not be used by individuals who:

Have a known allergy or sensitivity to copper or other heavy metals

Have a copper-metabolism disorder, such as Wilson's disease or Menkes disease

Have had an allergic reaction to GHK-Cu or any ingredient in the formulation

Have active liver disease or kidney failure (stage 4 or 5). Copper is cleared primarily by the liver, and impaired clearance raises the risk of copper accumulation

Have a zinc deficiency or transfusion-dependent anemia

Are pregnant, may become pregnant, or are breastfeeding

Have an active malignancy (cancer) without medical clearance

Are under 18 years of age

Have an active skin or soft-tissue infection at the intended injection site

Precautions and Warnings

Inform your provider if you have or have had:

Any copper or heavy-metal sensitivity, even if mild or historical

Liver or kidney conditions of any severity

Low zinc levels or a history of anemia. Copper and zinc compete for absorption, and sustained copper exposure can deplete zinc over time. Your provider may monitor levels or suggest zinc supplementation

Any history of cancer

A bleeding disorder, or you take an anticoagulant

Uncontrolled chronic illness

Tell your provider about all medications and supplements you take, including copper- or zinc-containing supplements and multivitamins, and any GLP-1 medication such as semaglutide or tirzepatide.

Common Side Effects

Because human data on injectable GHK-Cu is limited, the full side effect profile is not well characterized. Reported effects are generally mild, local, and temporary, and may include:

Injection site redness, swelling, itching, or discomfort

Temporary skin discoloration at the injection site

Headache

Nausea or digestive upset

Fatigue

If you experience any severe or prolonged symptoms, notify your provider immediately.

Serious Reactions (Rare)

In rare cases, patients may experience:

Hypersensitivity or allergic reaction

Signs of copper excess, which may include persistent nausea, abdominal pain, or unusual fatigue. Report these to your provider promptly

Infection at the injection site

Worsening of pre-existing conditions

Stop treatment and seek medical attention immediately if you experience trouble breathing, chest pain, or swelling of the face, lips, or throat.

Use and Administration

Use injectable GHK-Cu only as directed by your licensed provider.

Do not exceed the prescribed dosage or frequency. More is not better, and sustained copper exposure carries its own risks.

GHK-Cu is administered via subcutaneous injection, on the schedule your provider sets.

Rotate injection sites to reduce the chance of local reactions.

Do not inject the topical cream, and do not apply the injectable formulation to the skin. They are different products, prepared differently.

If you miss a dose, contact your provider for guidance before resuming.

Report any adverse effects or unexpected symptoms during treatment.

Storage and Disposal

Store GHK-Cu as directed on the pharmacy label, typically refrigerated and protected from light. Do not use expired products. Dispose of needles and syringes in an approved sharps container. Keep out of reach of children.